"In vitro evaluation of sulbactam combination therapies for Acinetobacter baumannii"
{{output}}
Background and objectives: Acinetobacter baumannii, a leading cause of hospital-acquired infections in critically ill patients, is increasingly resistant to carbapenems, leading WHO to designate carbapenem-resistant Acinetobacter... ...